17 Capital Partners’s MicroSectors FANG+ ETNs due Jan 8 2038 FNGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,145
Closed -$850K 167
2025
Q3
$850K Buy
12,145
+1,155
+11% +$77.1K 0.46% 78
2025
Q2
$716K Buy
10,990
+1,732
+19% +$97.7K 0.41% 83
2025
Q1
$461K Buy
9,258
+1,010
+12% +$56.9K 0.3% 104
2024
Q4
$473K Buy
8,248
+780
+10% +$41.9K 0.3% 95
2024
Q3
$369K Buy
7,468
+1,583
+27% +$76.7K 0.24% 111
2024
Q2
$289K Buy
+5,885
New +$264K 0.21% 113

Other funds holding FNGS

17 Capital Partners's FNGS Position: Q4 2025 in Review

17 Capital Partners sold out of MicroSectors FANG+ ETNs due Jan 8 2038 (FNGS) in Q4 2025, closing a stake of 12,145 shares — an estimated $850K sold.

17 Capital Partners first reported a position in FNGS in Q2 2024 and held it in 6 quarters. The position peaked at $850K in Q3 2025. 44 funds tracked by Wall St. Rank hold FNGS as of Q4 2025.

  • 17 Capital Partners reported no remaining MicroSectors FANG+ ETNs due Jan 8 2038 position as of Q4 2025 after selling out during the quarter.
  • 17 Capital Partners sold 12,145 MicroSectors FANG+ ETNs due Jan 8 2038 shares in Q4 2025, an estimated $850K.
  • 17 Capital Partners first reported a position in MicroSectors FANG+ ETNs due Jan 8 2038 in Q2 2024 and held it in 6 quarters.
  • 17 Capital Partners's MicroSectors FANG+ ETNs due Jan 8 2038 position peaked at $850K in Q3 2025.
  • 44 funds tracked by Wall St. Rank held MicroSectors FANG+ ETNs due Jan 8 2038 as of Q4 2025.

Based on 17 Capital Partners's 13F filing for Q4 2025, filed 13 Feb 2026.